The iShares Biotechnology ETF (IBB) shed 2%.
In corporate news, Compass Therapeutics (CMPX) shares fell 4.8% after Wedbush downgraded the stock to neutral from outperform and cut the price target to $1 from $5.
http://www.mtnewswires.com
Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.